Onno W Kranenburg

35PUBLICATIONS
167CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Oct 22, 2026
Survival impact of involvement of lymph node stations 16b1, 9, and 8a during pancreatoduodenectomy for pancreatic and periampullary cancers (PANODE): prospective multicentre study.

|Oct 22, 2026
DuoBody®-FAPαxDR4 is a novel DR4 agonist that induces potent antitumor activity through FAPα-dependent, DR4-transactivation-mediated apoptosis.

|Aug 31, 2026
ATR inhibitors synergise with mitomycin C to enhance cytotoxicity in patient-derived non-muscle invasive bladder cancer organoids.

|Jun 22, 2026
Surgical outcomes from nationwide implementation of the international best practice for locally advanced pancreatic cancer (PREOPANC-4) study.

|Apr 15, 2026
Emergence of oncofetal plasticity is ubiquitous in early colorectal cancers.

|Jan 06, 2026
Targeting the DNA damage response prevents regrowth of colorectal peritoneal metastasis-derived organoids following treatment with mitomycin C.

Kyah van Megesen, Arianna Stefan, Madelief Kieboom

Pageof 6

Frequent Collaborators

5 joint publications

Marc G Besselink

4 joint publications

Emre Küçükköse

4 joint publications

Olivier R Busch

3 joint publications

Richard P Meijer